Phamacovigilance/Regulatory

Prescribers and users of our medicines are encouraged to report any adverse effects that they suspect might be associated with a medicine, or product quality complaints that they fear may have an impact on patient safety. The objective of comprehensive reporting and monitoring is to ultimately lead to the safer use of medicines, while also helping to improve public health.

Reporting of adverse effects can be carried out by both health professionals and patients through three different routes:

To the Regulatory Affairs and Pharmacovigilance Department of Torrent Pharma (UK) Ltd:
A designated responsible person (either a physician or pharmacist) is appointed within this department to collect the first known points of information on adverse effects. Upon receiving this information, he forwards it to external pharmacovigilance service providers for assessment and reporting to MHRA, according to strict timeframes.

To APCER Pharma (Europe) Ltd:
This is the external pharmacovigilance service provider employed by Torrent to carry out the assessment and reporting to MHRA of adverse effects to Torrent's products licensed in the UK and other EU countries.  Designated staff are appointed to collect full information on adverse effects and input into a global pharmacovigilance database, from which the reports for MHRA are generated.

To the Pharmacovigilance Department of Torrent Pharmaceuticals Limited:
The parent company of  Torrent Pharma (UK) Ltd. also acts as external pharmacovigilance service provider.  It maintains the global pharmacovigilance database, and can receive adverse effects from all parts of the world.

To report adverse effects during Office hours, please contact:-

RA / PV department, Torrent Pharma UK Ltd., Unit 4 Charlwood Court, County Oak Way, Crawley, West Sussex, RH11 7XA
Telephone: +44 (0) 1293 574180
Mobile: +44 (0)7591 555940
Fax: +44 (0) 1293 5330003
Email: drugsafety@torrentpharma.co.uk

OR

Feel free to contact regarding any Query
 

Contact Details of Qualified Person Responsible for Pharmacovigilance (EU-QPPV) and Deputy QPPV Dr. Vineet Kacker

Qualified Person Responsible for Pharmacovigilance

Address: APCER Pharma (Europe) Ltd.

9th Floor, CP House, 97-107 Uxbridge Road, Ealing, London W5 5TL

Office: +44 (0) 20 8326 3220

Direct: +44 (0) 20 8326 3222

Mobile: +44 (0) 7753 606 357

E-Mail: vineet.kacker@apcerls.com

Dr. Vijaya Kumar Bathala

Deputy Qualified Person Responsible for Pharmacovigilance

Address: APCER Pharma (Europe) Ltd.

9th Floor, CP House, 97-107 Uxbridge Road, Ealing, London W5. 5TL

Office: +44 (0) 208 326 3220

Fax: +44 (0) 208 326 3221

Mobile: +44 (0) 7917 096158

E-Mail: Vijaya.bathala@apcerls.com
 

Contact Details of Global PV Team Dr. Niraj Limbachiya, Dr. Jasmin Radadia

Global Pharmacovigilance Responsible Person Deputy Global Pharmacovigilance Responsible Person

E-Mail: pv@torrentpharma.com
 

Contact Details of TPUK Team Address: RA / PV department, Torrent Pharma UK Ltd.,

Unit 4 Charlwood Court, County Oak Way, Crawley, West Sussex, RH11 7XA

Telephone: +44 (0) 1293 574180

Mobile: +44 (0)7591 555940

Fax: +44 (0) 1293 5330003

Email: drugsafety@torrentpharma.co.uk
 

To forward any adverse event report to APCER E-Mail: Torrent.ICSRTeam@apcerls.com

To report adverse effects Out-of-Hours, please contact: -

Pharmacovigilance Department, Torrent Pharmaceuticals Limited

Telephone: +44 (0) 7591 555940

Adverse event or Product Complaint Intimation Form is provided at: http://www.tplapp.com/aer/ComplaintForm/new_Complaint_intimation_tp.aspx?Flag=T

 Please forward all product quality complaints to Torrent Pharma (UK) Ltd.

Home | Products | Pharmacovigilance | Directions | Contact Us

Torrent Pharma (UK) Ltd

Aptil Pharma Ltd

Unit 4, Charlwood Court, County Oak Way, Crawley, West Sussex. RH11 7XA. United Kingdom

Telephone: +44 (0) 1293 574180 | Fax: +44 (0) 1293 533003 | Email: drugsafety@torrentpharma.co.uk

Copyright © 2012 Torrent Pharma (UK) Limited. All Rights Reserved.